393 related articles for article (PubMed ID: 16189915)
1. Beneficial and unusual punishment: an argument in support of prisoner participation in clinical trials.
Hoffman S
Indiana Law Rev; 2000; 33(2):475-515. PubMed ID: 16189915
[No Abstract] [Full Text] [Related]
2. Prisoner participation in biomedical research.
Hoffman S
Health Law News; 2000 Jun; 13(3):7, 14-5. PubMed ID: 12542045
[No Abstract] [Full Text] [Related]
3. U.S. prisoners' access to experimental HIV therapies.
Collins A; Baumgartner D; Henry K
Minn Med; 1995 Nov; 78(11):45-8. PubMed ID: 8531905
[TBL] [Abstract][Full Text] [Related]
4. State regulation of pharmaceutical clinical trials.
Gibbs JN
Food Drug Law J; 2004; 59(2):265-85. PubMed ID: 15298012
[No Abstract] [Full Text] [Related]
5. Prisoner participation in clinical research trials: a fundamental right under the eighth amendment?
Lee V
J Leg Med; 2012 Oct; 33(4):541-52. PubMed ID: 23216151
[No Abstract] [Full Text] [Related]
6. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver.
Kipnis K; King NM; Nelson RM
IRB; 2006; 28(2):16-9. PubMed ID: 16770884
[No Abstract] [Full Text] [Related]
7. No-consent trials raise concern.
Dove A
Nat Med; 1999 Mar; 5(3):250-1. PubMed ID: 10086366
[No Abstract] [Full Text] [Related]
8. The impact of escalating regulatory requirements on the conduct of clinical research.
Gordon BG; Kessinger A; Mann SL; Prentice ED
Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
[TBL] [Abstract][Full Text] [Related]
9. FDA. Proposed guidelines for emergency research aim to quell confusion.
Couzin J
Science; 2006 Sep; 313(5792):1372-3. PubMed ID: 16959979
[No Abstract] [Full Text] [Related]
10. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
Breslow LH
Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
[TBL] [Abstract][Full Text] [Related]
11. Forum on prisoners' access to clinical trials: summary of recommendations.
Stein GL; Headley LD
AIDS Public Policy J; 1996; 11(1):3-20. PubMed ID: 10915234
[No Abstract] [Full Text] [Related]
12. Continued concern: human subject protection, the institutional review board, and continuing review.
Hoffman S
Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
[No Abstract] [Full Text] [Related]
13. Clinical trials face heightened scrutiny as science and commerce appear to merge.
Lorman AJ
J Biolaw Bus; 2001; 4(4):23-32. PubMed ID: 12751494
[TBL] [Abstract][Full Text] [Related]
14. US ponders unlocking the gates to prisoner research.
Waltz E
Nat Med; 2006 Jan; 12(1):3. PubMed ID: 16397531
[No Abstract] [Full Text] [Related]
15. IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.
Cohen J;
AIDS Read; 2001 Jan; 11(1):41-2. PubMed ID: 11215087
[TBL] [Abstract][Full Text] [Related]
16. New European rules regarding the approval of clinical trials, the role of ethics committees and the protection of subjects.
Nys H
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):405-14. PubMed ID: 23064523
[No Abstract] [Full Text] [Related]
17. When informed consent is not required in studies.
Maloney DM
Hum Res Rep; 2006 Jun; 21(6):3. PubMed ID: 17111532
[No Abstract] [Full Text] [Related]
18. And some grow mad, and all grow bad: prisoners' constitutional right to receive psychiatric treatment.
Jennings EM
N Engl J Crim Civ Confin; 1985; 11(1):160-85. PubMed ID: 16100811
[No Abstract] [Full Text] [Related]
19. Research infrastructure and IRB/FDA requirements.
Cohen J
Med Health R I; 2000 Dec; 83(12):382-5. PubMed ID: 11190124
[No Abstract] [Full Text] [Related]
20. HIV clinical trials in correctional settings: right or retrogression?
De Groot AS; Bick J; Thomas D; Stubblefield E
AIDS Read; 2001 Jan; 11(1):34-40. PubMed ID: 11215086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
